Die Suchmaschine für Unternehmensdaten in Europa
UK-Förderung (257.764 £): BRAZZX - Developing a scalable and predictable fermentation process for Brazzein, a new, non-caloric protein sweetener Ukri01.03.2022 Forschung und Innovation im Vereinigten Königreich, Großbritannien
Auf einen Blick
Text
BRAZZX - Developing a scalable and predictable fermentation process for Brazzein, a new, non-caloric protein sweetener
| Zusammenfassung | Calorie gluttony due to sugar over-consumption has led to a worldwide epidemic of obesity and diabetes. The recent statistics highlighting the high propensity of obese and diabetic individuals to require hospitalization and intensive care during COVID infection is a wakeup call for the world to tackle the sugar reduction agenda with renewed urgency. Current non-caloric sweeteners have not met the aims of previous sugar reduction efforts. This is primarily due to the unfavourable sweet taste profile of most of these sweeteners. Moreover, prolonged consumption of some artificial sweeteners has been shown to result in negative health consequences. Consumers demand a non-caloric sweetener that actually tastes like sugar and can be produced on a commercial scale. **Magellan is developing Brazzein as the next generation of non-caloric, natural sweeteners to overcome the limitations of currently available alternatives.** Brazzein is a natural protein molecule that is found in a rare West African fruit and has been consumed by humans and primates for centuries. The sweet taste quality of Brazzein is remarkably similar to tabletop sugar. Moreover, being 1500x sweeter than sugar, one would need to use very little of this sweetener in beverages and food, resulting in negligible calories being consumed. Magellan is developing a scalable and cost effective manufacturing platform for this remarkable natural molecule in order to advance the war against sugar. |
| Kategorie | Collaborative R&D |
| Referenz | 10022895 |
| Status | Closed |
| Laufzeit von | 01.03.2022 |
| Laufzeit bis | 31.08.2023 |
| Fördersumme | 257.764,00 £ |
| Quelle | https://gtr.ukri.org/projects?ref=10022895 |
Beteiligte Organisationen
| MAGELLAN LIFE SCIENCES LIMITED |
257.764,00 £ |
Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider. Der aktuelle Stand wird auf folgender Seite wiedergegeben: Magellan Life Sciences Ltd., London, Großbritannien.
Die Visualisierungen zu "Magellan Life Sciences Ltd. - UK-Förderung (257.764 £): BRAZZX - Developing a scalable and predictable fermentation process for Brazzein, a new, non-caloric protein sweetener"
werden von
North Data
zur Weiterverwendung unter einer
Creative Commons Lizenz
zur Verfügung gestellt.
